Literature DB >> 31886451

Parental Perspectives on Whole Exome Sequencing in Pediatric Cancer: A Typology of Perceived Utility.

Janet Malek1, Melody J Slashinski2, Jill O Robinson1, Amanda M Gutierrez1, D Williams Parsons3,4, Sharon E Plon3,4, Laurence B McCullough1, Amy L McGuire1.   

Abstract

PURPOSE: To explore how parents of pediatric cancer patients perceived the utility of clinical tumor and germline whole-exome sequencing (WES) results. PATIENTS AND METHODS: We conducted longitudinal interviews with parents of a diverse pediatric cancer population before disclosure of WES results (n=64), then one to eight months (n=33) after disclosure. Interview transcripts were analyzed using a thematic qualitative approach.
RESULTS: Parents identified a broad range of types of utility for their child's WES results. Even when results did not affect their child's current treatment, they expressed optimism about future clinical utility for their child, themselves, and other family members. Parents also reported experiencing psychological utility including peace of mind, relief of guilt, and satisfaction of curiosity. Pragmatic utility, such as the ability to plan for the future and make better reproductive decisions, was also described.
CONCLUSION: Parents of pediatric cancer patients perceive WES to have broad utility, including psychological and pragmatic utility, even if there is no direct impact on clinical care. Further work will need to consider how the value of genomic information should be characterized, how risks and benefits should be described, and how these results should inform recommendations and decisions about using WES.

Entities:  

Year:  2017        PMID: 31886451      PMCID: PMC6934167          DOI: 10.1200/PO.17.00010

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN: 2473-4284


  24 in total

1.  Disclosing individual results of clinical research: implications of respect for participants.

Authors:  David I Shalowitz; Franklin G Miller
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

2.  Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders.

Authors:  Marian Reiff; Ellen Giarelli; Barbara A Bernhardt; Ebony Easley; Nancy B Spinner; Pamela L Sankar; Surabhi Mulchandani
Journal:  J Autism Dev Disord       Date:  2015-10

3.  Personal utility in genomic testing: is there such a thing?

Authors:  Eline M Bunnik; A Cecile J W Janssens; Maartje H N Schermer
Journal:  J Med Ethics       Date:  2014-05-28       Impact factor: 2.903

Review 4.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.

Authors:  Jeffrey R Botkin; John W Belmont; Jonathan S Berg; Benjamin E Berkman; Yvonne Bombard; Ingrid A Holm; Howard P Levy; Kelly E Ormond; Howard M Saal; Nancy B Spinner; Benjamin S Wilfond; Joseph D McInerney
Journal:  Am J Hum Genet       Date:  2015-07-02       Impact factor: 11.025

5.  Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.

Authors:  Colin Me Halverson; Kristin E Clift; Jennifer B McCormick
Journal:  J Community Genet       Date:  2016-02-09

6.  Is Whole-Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients With Solid Tumors.

Authors:  Laurence B McCullough; Melody J Slashinski; Amy L McGuire; Richard L Street; Christine M Eng; Richard A Gibbs; D William Parsons; Sharon E Plon
Journal:  Pediatr Blood Cancer       Date:  2015-10-27       Impact factor: 3.167

7.  Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics.

Authors: 
Journal:  Genet Med       Date:  2015-03-12       Impact factor: 8.822

8.  Parents' interest in whole-genome sequencing of newborns.

Authors:  Aaron J Goldenberg; Daniel S Dodson; Matthew M Davis; Beth A Tarini
Journal:  Genet Med       Date:  2013-06-06       Impact factor: 8.822

9.  Parents are interested in newborn genomic testing during the early postpartum period.

Authors:  Susan E Waisbren; Danielle K Bäck; Christina Liu; Sarah S Kalia; Steven A Ringer; Ingrid A Holm; Robert C Green
Journal:  Genet Med       Date:  2014-12-04       Impact factor: 8.822

10.  Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.

Authors:  D Williams Parsons; Angshumoy Roy; Yaping Yang; Tao Wang; Sarah Scollon; Katie Bergstrom; Robin A Kerstein; Stephanie Gutierrez; Andrea K Petersen; Abhishek Bavle; Frank Y Lin; Dolores H López-Terrada; Federico A Monzon; M John Hicks; Karen W Eldin; Norma M Quintanilla; Adekunle M Adesina; Carrie A Mohila; William Whitehead; Andrew Jea; Sanjeev A Vasudevan; Jed G Nuchtern; Uma Ramamurthy; Amy L McGuire; Susan G Hilsenbeck; Jeffrey G Reid; Donna M Muzny; David A Wheeler; Stacey L Berg; Murali M Chintagumpala; Christine M Eng; Richard A Gibbs; Sharon E Plon
Journal:  JAMA Oncol       Date:  2016-05-01       Impact factor: 31.777

View more
  7 in total

Review 1.  Conceptualization of utility in translational clinical genomics research.

Authors:  Hadley Stevens Smith; Kyle B Brothers; Sara J Knight; Sara L Ackerman; Christine Rini; David L Veenstra; Amy L McGuire; Benjamin S Wilfond; Janet Malek
Journal:  Am J Hum Genet       Date:  2021-10-22       Impact factor: 11.025

Review 2.  Perceived Utility of Genomic Sequencing: Qualitative Analysis and Synthesis of a Conceptual Model to Inform Patient-Centered Instrument Development.

Authors:  Hadley Stevens Smith; Stephanie R Morain; Jill Oliver Robinson; Isabel Canfield; Janet Malek; Caryn Kseniya Rubanovich; Cinnamon S Bloss; Sara L Ackerman; Barbara Biesecker; Kyle B Brothers; Crispin N Goytia; Carol R Horowitz; Sara J Knight; Barbara Koenig; Stephanie A Kraft; Simon Outram; Christine Rini; Kelly J Shipman; Margaret Waltz; Benjamin Wilfond; Amy L McGuire
Journal:  Patient       Date:  2021-10-18       Impact factor: 3.481

3.  Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.

Authors:  Jill O Robinson; Julia Wynn; Barbara Biesecker; Leslie G Biesecker; Barbara Bernhardt; Kyle B Brothers; Wendy K Chung; Kurt D Christensen; Robert C Green; Amy L McGuire; M Ragan Hart; Ida Griesemer; Donald L Patrick; Christine Rini; David Veenstra; Angel M Cronin; Stacy W Gray
Journal:  Genet Med       Date:  2019-06-13       Impact factor: 8.822

4.  Responsibility, culpability, and parental views on genomic testing for seriously ill children.

Authors:  Janet Malek; Stacey Pereira; Jill O Robinson; Amanda M Gutierrez; Melody J Slashinski; D Williams Parsons; Sharon E Plon; Amy L McGuire
Journal:  Genet Med       Date:  2019-06-12       Impact factor: 8.864

5.  Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium.

Authors:  Amanda M Gutierrez; Jill O Robinson; Simon M Outram; Hadley S Smith; Stephanie A Kraft; Katherine E Donohue; Barbara B Biesecker; Kyle B Brothers; Flavia Chen; Benyam Hailu; Lucia A Hindorff; Hannah Hoban; Rebecca L Hsu; Sara J Knight; Barbara A Koenig; Katie L Lewis; Kristen Hassmiller Lich; Julianne M O'Daniel; Sonia Okuyama; Gail E Tomlinson; Margaret Waltz; Benjamin S Wilfond; Sara L Ackerman; Mary A Majumder
Journal:  J Clin Transl Sci       Date:  2021-09-14

6.  Factors Associated with Declining to Participate in a Pediatric Oncology Next Generation Sequencing Study.

Authors:  Katianne M Howard Sharp; Niki Jurbergs; Annastasia Ouma; Lynn Harrison; Elsie Gerhardt; Leslie Taylor; Kayla Hamilton; Rose B McGee; Regina Nuccio; Emily Quinn; Stacy Hines-Dowell; Chimene Kesserwan; Anusha Sunkara; Jami S Gattuso; Michelle Pritchard; Belinda Mandrell; Mary V Relling; Cyrine E Haidar; Guolian Kang; Liza M Johnson; Kim E Nichols
Journal:  JCO Precis Oncol       Date:  2020-03-24

7.  Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications.

Authors:  Hadley Stevens Smith; Amy L McGuire; Eve Wittenberg; Tara A Lavelle
Journal:  Per Med       Date:  2021-03-17       Impact factor: 2.512

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.